Search

Search Constraints

You searched for: Author/Creator Bois, Andreas du

Search Results

1. 2022-RA-1515-ESGO Impact of surgical staging on survival of low grade endometrioid ovarian cancer apparently confined to the ovary. (20th October 2022)

2. 2022-RA-1533-ESGO Role of fertility sparing surgery in patients with borderline ovarian tumors. (20th October 2022)

3. 2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial. (20th October 2022)

4. 2022-RA-285-ESGO Real world data of treatment and outcome of patients with early ovarian cancer (FIGO I) in Germany (QS Ovar of the AGO Study Group). (20th October 2022)

5. 2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group). (20th October 2022)

6. 2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM. (20th October 2022)

7. 2022-RA-798-ESGO Diagnosis of first relapse and its impact on quality of life in patients with advanced ovarian cancer (AGO-OVAR 19/II). (20th October 2022)

9. 431 Histopathological results after risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: single center experience. (4th December 2020)

10. 441 Chemotherapy response score: correlation with preoperative serological and radiological assessment of response and clinical implications in ovarian cancer patients. (4th December 2020)